Ondansetron Tablet, Film Coated
Product Images NDC 43063-770

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 43063-770). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063770 Label (43063770)

Label for Ondansetron USP 8 mg, oral film-coated tablets, packaged in a 6-tablet count. The label includes the NDC number 43063-770-06 and shows PD-Rx Pharmaceuticals, Inc. as the labeler, based in Oklahoma City, OK. It also provides reorder and lot information, expiration date of 01/2050, and a warning to keep out of reach of children.*

FDA Label Image

Structure-base (Structure Base)

Chemical structure of ondansetron, showing its molecular framework with a ketone group and methyl-substituted nitrogen-containing rings.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate, showing the molecular arrangement including a fused ring system, methyl groups, and hydrochloride with two water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.